Why cbdMD Inc (YCBD)’s Management is Optimistic After March Quarter Results

cbdMD Inc (NYSEAMERICAN:YCBD) is one of the best CBD stocks to buy right now. The stock has gained around 35% over the past six months, and analysts see more upside potential, expecting the stock to surge more than 160% over the next 12 months.

Why cbdMD Inc (YCBD)’s Management is Optimistic After March Quarter Results

el Comandante/Shutterstock.com

cbdMD Inc (NYSEAMERICAN:YCBD) reported its March quarter results on May 14. The report showed revenue increased 19% YoY and 12% sequentially to $5.6 million. The company said the topline growth reflected continued momentum in its core business as well as contributions from the newly acquired Bluebird Botanicals.

Bluebird is a long-standing and respected brand in the CBD industry. According to Ronan Kennedy, the CEO of CbdMD, the Bluebird acquisition is a case study for what they can do and sets the template for additional strategic acquisitions.

Looking ahead, the CbdMD management expects Bluebird to contribute more to both its topline and earnings as operational efficiencies are realized and additional products are rolled out. With the integration of Bluebird, CbdMD expects to realize operational efficiencies through consolidated manufacturing, supply chain, and shared services. In addition, the management expects the expanded product offering and cross-brand distribution to accelerate revenue growth.

Beyond the expected Bluebird contribution, the CbdMD management is also excited about the opportunities in the CMS BEI Medicare pathway activation. This program allows participants in certain centers to consult about incorporating hemp products to improve symptom control.

cbdMD Inc (NYSEAMERICAN:YCBD) produces and distributes hemp-derived CBD products for wellness. Its portfolio includes CBD oils, gummies, and sleep aids. While the company primarily offers CBD products for human consumption, it also provides pet-specific products.

While we acknowledge the risk and potential of YCBD as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than YCBD and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Most Buzzing AI Semiconductor Stocks to Buy in 2026 and 11 Best Medical Technology Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey on Google News.

1281292 - 11759070 - 1